Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products. It specializes in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies.
Akorn was acquired by Fresenius Kabi AG on April 24, 2017.

Parent Company
Fresenius Kabi
Lake Forest, US
Size (employees)
2,261 (est)
Akorn was founded in 1948 and is headquartered in Lake Forest, US

Akorn Office Locations

Akorn has offices in Lake Forest, Ann Arbor, Gurugram and Jersey
Lake Forest, US (HQ)
300 1925 W Field Ct
Gurugram, IN
Dlf Building Number 9 B
Ann Arbor, US
2929 Plymouth Rd

Akorn Data and Metrics

Akorn Financial Metrics

Akorn's revenue was reported to be $1.1 b in FY, 2016 which is a 13% increase from the previous period.
$, USD

Revenue (FY, 2016)

1.1 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

674.3 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

184.2 m

EBIT (FY, 2016)

327.6 m

Market capitalization (23-Jun-2017)

4.2 b

Closing share price (23-Jun-2017)


Cash (31-Dec-2016)

200.8 m
Akorn's current market capitalization is $4.2 b.
$, USDFY, 2013FY, 2014FY, 2015FY, 2016


317.7 m593.1 m985.1 m1.1 b

Revenue growth, %


Cost of goods sold

145.8 m295.5 m105.5 m442.6 m

Gross profit

171.9 m297.6 m879.5 m674.3 m

Gross profit Margin, %


Operating expense total

83.7 m200.9 m301.4 m346.7 m


88.2 m96.7 m294.6 m327.6 m

EBIT margin, %


Interest expense

8.6 m35.7 m12.6 m42.7 m

Pre tax profit

82.9 m59.1 m49.5 m271.3 m

Income tax expense

30.5 m23.3 m16.7 m87.1 m

Net Income

52.4 m35.3 m150.8 m184.2 m
$, USDFY, 2013FY, 2014FY, 2015FY, 2016


34.2 m70.7 m346.3 m200.8 m


5.8 m30.9 m20 m26 m

Current Assets

168.9 m494.3 m751.2 m685.8 m


82.1 m143.8 m179.6 m238.4 m


29.8 m278.8 m284.7 m284.3 m

Total Assets

431.8 m1.9 b2.1 b2 b

Accounts Payable

23 m44.1 m46 m59.5 m

Current Liabilities

61.2 m134.2 m231.5 m175.6 m

Non-Current Liabilities

110.4 m1.4 b1.3 b979 m

Total Liabilities

171.6 m1.5 b1.5 b1.2 b

Retained Earnings

15.4 m50.7 m180 m319.3 m

Total Equity

260.2 m621.6 m819.2 m

Financial Leverage

1.7 x3.4 x2.4 x
$, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

52.4 m35.3 m37.5 m184.2 m

Depreciation and Amortization

7.4 m44.1 m17.1 m65.7 m

Accounts Receivable

(14 m)


(3.8 m)(13 m)2.9 m(6.5 m)

Accounts Payable

2 m11 m7.9 m6.1 m

Cash From Operating Activities

57.3 m30.9 m45.3 m167.8 m

Purchases of PP&E

(11.6 m)(29.6 m)(7.1 m)(74.9 m)

Cash From Investing Activities

(66.9 m)(966.5 m)(29.4 m)(72.9 m)

Cash From Financing Activities

3.1 m972.3 m36.8 m(240.3 m)
Y, 2016

Financial Leverage

2.4 x

Akorn Market Value History

Akorn Median Salaries

Source: 75 public H-1B filings from Akorn

Akorn Company Life and Culture

You may also be interested in